Relative bioavailability of danazol in dogs from liquid-filled hard gelatin capsules. 1999

L Erlich, and D Yu, and D A Pallister, and R S Levinson, and D G Gole, and P A Wilkinson, and R E Erlich, and L E Reeve, and T X Viegas
Apotex Pharmaceuticals, Weston, Ont. M9L2Y6, Canada.

Danazol was dissolved in non-aqueous mixtures containing either polyethylene glycol 400 or polysorbate 80, and filled into hard gelatin capsules at 50 mg concentrations. The bioavailability of these formulations was compared with commercial danazol capsules in a two-way crossover study using young female beagle dogs. Both formulations showed greater oral bioavailability when compared with either the 100 or 200 mg commercial brand of danazol. The bioavailability of the polyethylene glycol 400 and polysorbate 80 formulations was enhanced 3.7 and 15.8 times, respectively, when compared at the 100 mg dose level.

UI MeSH Term Description Entries
D011136 Polysorbates Sorbitan mono-9-octadecanoate poly(oxy-1,2-ethanediyl) derivatives; complex mixtures of polyoxyethylene ethers used as emulsifiers or dispersing agents in pharmaceuticals. Polysorbate,Polysorbate 20,Polysorbate 80,Sorbitan Derivatives,Tween,Tweens,PSML,Polyoxyethylene Sorbitan Monolaurate,Tween 20,Tween 60,Tween 80,Tween 81,Tween 85,20s, Polysorbate,20s, Tween,60s, Tween,80s, Polysorbate,80s, Tween,81s, Tween,85s, Tween,Derivative, Sorbitan,Derivatives, Sorbitan,Monolaurate, Polyoxyethylene Sorbitan,Monolaurates, Polyoxyethylene Sorbitan,PSMLs,Polyoxyethylene Sorbitan Monolaurates,Polysorbate 20s,Polysorbate 80s,Sorbitan Derivative,Sorbitan Monolaurate, Polyoxyethylene,Sorbitan Monolaurates, Polyoxyethylene,Tween 20s,Tween 60s,Tween 80s,Tween 81s,Tween 85s
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D003613 Danazol A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders. Azol,Cyclomen,Danatrol,Danazant,Danazol-Ratiopharm,Danocrine,Danol,Danoval,Ladogal,Norciden,Panacrine,Danazol Ratiopharm
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004965 Estrogen Antagonists Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. Estradiol Antagonists,Antagonists, Estradiol,Antagonists, Estrogen
D005079 Excipients Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc. Excipient,Stabilizing Agent,Stabilizing Agents,Suspending Agent,Suspending Agents,Agent, Stabilizing,Agent, Suspending,Agents, Stabilizing,Agents, Suspending
D005260 Female Females
D005780 Gelatin A product formed from skin, white connective tissue, or bone COLLAGEN. It is used as a protein food adjuvant, plasma substitute, hemostatic, suspending agent in pharmaceutical preparations, and in the manufacturing of capsules and suppositories. Gelafusal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

L Erlich, and D Yu, and D A Pallister, and R S Levinson, and D G Gole, and P A Wilkinson, and R E Erlich, and L E Reeve, and T X Viegas
March 2008, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
L Erlich, and D Yu, and D A Pallister, and R S Levinson, and D G Gole, and P A Wilkinson, and R E Erlich, and L E Reeve, and T X Viegas
August 1991, Pharmaceutical research,
L Erlich, and D Yu, and D A Pallister, and R S Levinson, and D G Gole, and P A Wilkinson, and R E Erlich, and L E Reeve, and T X Viegas
March 1976, Journal of pharmaceutical sciences,
L Erlich, and D Yu, and D A Pallister, and R S Levinson, and D G Gole, and P A Wilkinson, and R E Erlich, and L E Reeve, and T X Viegas
April 1977, The Journal of pharmacy and pharmacology,
L Erlich, and D Yu, and D A Pallister, and R S Levinson, and D G Gole, and P A Wilkinson, and R E Erlich, and L E Reeve, and T X Viegas
March 1974, Pharmaceutica acta Helvetiae,
L Erlich, and D Yu, and D A Pallister, and R S Levinson, and D G Gole, and P A Wilkinson, and R E Erlich, and L E Reeve, and T X Viegas
March 2012, Die Pharmazie,
L Erlich, and D Yu, and D A Pallister, and R S Levinson, and D G Gole, and P A Wilkinson, and R E Erlich, and L E Reeve, and T X Viegas
August 2006, Drug development and industrial pharmacy,
L Erlich, and D Yu, and D A Pallister, and R S Levinson, and D G Gole, and P A Wilkinson, and R E Erlich, and L E Reeve, and T X Viegas
October 1991, Journal of clinical pharmacy and therapeutics,
L Erlich, and D Yu, and D A Pallister, and R S Levinson, and D G Gole, and P A Wilkinson, and R E Erlich, and L E Reeve, and T X Viegas
June 1972, Acta pharmaceutica Suecica,
L Erlich, and D Yu, and D A Pallister, and R S Levinson, and D G Gole, and P A Wilkinson, and R E Erlich, and L E Reeve, and T X Viegas
January 1984, Journal de pharmacie de Belgique,
Copied contents to your clipboard!